Intrepid research, LLC

Cincinnati, Ohio 45245

2 studies enrolling now · 14 studies all time

What they study most

Cataplexy, EDS, Excessive Daytime Sleepiness, Fatigue, Idiopathic Hypersomnia, Impaired Cognitive Function, Narcolepsy, Narcolepsy Type 1 (NT1), Narcolepsy With Cataplexy, Narcolepsy Without Cataplexy, OSA, Obstructive Sleep Apnea

Studies at this site

• A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy — Recruiting now
• Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea — Running, not enrolling
• A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy — Completed
• Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study — Completed
• A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia — Completed
• A Study to Learn About How Elinzanetant Works and How Safe it is in Women Having Sleep Disturbances Associated With Menopause — Completed
• A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1 — Completed
• Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation
• A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy — Completed
• A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia — Completed
• An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy — Completed
• A Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Participants With Moderate to Severe Obstructive Sleep Apnea, and in Adult and Elderly Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease — Completed
• Crossover Trial of AD182 and AD504 in Obstructive Sleep Apnea — Completed
• Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy — NO_LONGER_AVAILABLE